Developmental pharmacokinetics of psychotropic drugs: olanzapine

Trial Profile

Developmental pharmacokinetics of psychotropic drugs: olanzapine

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Bipolar disorders; Psychotic disorders
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Acronyms DSIR-CT-M
  • Most Recent Events

    • 27 Jan 2014 Status changed from active, no longer recruiting to discontinued as per ClinicalTrials.gov record.
    • 28 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top